Dominant ELOVL1 mutation causes neurological disorder with ichthyotic keratoderma, spasticity, hypomyelination and dysmorphic features

Background Ichthyosis and neurological involvement occur in relatively few known Mendelian disorders caused by mutations in genes relevant both for epidermis and neural function. Objectives To identify the cause of a similar phenotype of ichthyotic keratoderma, spasticity, mild hypomyelination (on MRI) and dysmorphic features (IKSHD) observed in two unrelated paediatric probands without family history of disease. Methods Whole exome sequencing was performed in both patients. The functional effect of prioritised variant in ELOVL1 (very-long-chain fatty acids (VLCFAs) elongase) was analysed by VLCFA profiling by gas chromatography–mass spectrometry in stably transfected HEK2932 cells and in cultured patient’s fibroblasts. Results Probands shared novel heterozygous ELOVL1 p.Ser165Phe mutation (de novo in one family, while in the other family, father could not be tested). In transfected cells p.Ser165Phe: (1) reduced levels of FAs C24:0-C28:0 and C26:1 with the most pronounced effect for C26:0 (P=7.8×10−6 vs HEK293 cells with wild type (wt) construct, no difference vs naïve HEK293) and (2) increased levels of C20:0 and C22:0 (P=6.3×10−7, P=1.2×10−5, for C20:0 and C22:0, respectively, comparison vs HEK293 cells with wt construct; P=2.2×10−7, P=1.9×10−4, respectively, comparison vs naïve HEK293). In skin fibroblasts, there was decrease of C26:1 (P=0.014), C28:0 (P=0.001) and increase of C20:0 (P=0.033) in the patient versus controls. There was a strong correlation (r=0.92, P=0.008) between the FAs profile of patient’s fibroblasts and that of p.Ser165Phe transfected HEK293 cells. Serum levels of C20:0–C26:0 FAs were normal, but the C24:0/C22:0 ratio was decreased. Conclusion The ELOVL1 p.Ser165Phe mutation is a likely cause of IKSHD.

[1]  J. Fischer,et al.  Inherited Nonsyndromic Ichthyoses: An Update on Pathophysiology, Diagnosis and Treatment , 2017, American Journal of Clinical Dermatology.

[2]  Xu Zheng,et al.  Inhibition of Mammalian Target of Rapamycin Complex 1 (mTORC1) Downregulates ELOVL1 Gene Expression and Fatty Acid Synthesis in Goat Fetal Fibroblasts , 2015, International journal of molecular sciences.

[3]  R. Wanders,et al.  Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis. , 2015, Biochimica et biophysica acta.

[4]  F. Tempia,et al.  ELOVL5 mutations cause spinocerebellar ataxia 38. , 2014, American journal of human genetics.

[5]  E. Bertini,et al.  Hypomyelinating leukodystrophies: Translational research progress and prospects , 2014, Annals of neurology.

[6]  G. Rouleau,et al.  Expanding the clinical phenotype associated with ELOVL4 mutation: study of a large French-Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia. , 2014, JAMA neurology.

[7]  P. Stepnowski,et al.  Identification of Cyclopropaneoctanoic Acid 2-Hexyl in Human Adipose Tissue and Serum , 2013, Lipids.

[8]  S. Itohara,et al.  Impaired Epidermal Permeability Barrier in Mice Lacking Elovl1, the Gene Responsible for Very-Long-Chain Fatty Acid Production , 2013, Molecular and Cellular Biology.

[9]  A. Kihara Very long-chain fatty acids: elongation, physiology and related disorders. , 2012, Journal of biochemistry.

[10]  S. Elledge,et al.  SLIC: a method for sequence- and ligation-independent cloning. , 2012, Methods in molecular biology.

[11]  F. Alkuraya,et al.  Recessive mutations in ELOVL4 cause ichthyosis, intellectual disability, and spastic quadriplegia. , 2011, American journal of human genetics.

[12]  Josyf Mychaleckyj,et al.  Robust relationship inference in genome-wide association studies , 2010, Bioinform..

[13]  Shota Suto,et al.  ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis , 2010, Proceedings of the National Academy of Sciences.

[14]  R. Wanders,et al.  The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy , 2010, EMBO molecular medicine.

[15]  J. Weissman,et al.  A Molecular Caliper Mechanism for Determining Very Long-Chain Fatty Acid Length , 2007, Cell.

[16]  B. Jayaprakasam,et al.  Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity Published, JLR Papers in Press, June 21, 2006. , 2006, Journal of Lipid Research.

[17]  R. Westerberg,et al.  Fatty acid elongases in mammals: their regulation and roles in metabolism. , 2006, Progress in lipid research.

[18]  M. Metzker,et al.  A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy , 2001, Nature Genetics.

[19]  P. Tvrdik,et al.  Role of a New Mammalian Gene Family in the Biosynthesis of Very Long Chain Fatty Acids and Sphingolipids , 2000, The Journal of cell biology.